L-asparaginase treatment of acute myeloblastic leukemia

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2010

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

Annals of oncology : official journal of the European Society for Medical Oncology·2007

Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2003

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.

Cancer·2001

Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.

Health psychology : official journal of the Division of Health Psychology, American Psychological Association·2001

Burnout: caring for the caregivers.

The oncologist·2000

Glucose metabolism assessed by fluorodeoxyglucose positron emission tomography and response to chemoimmunotherapy in esophageal squamous cell carcinoma: An exploratory analysis.

Oncology·2026

Biomarker-Oriented Contextual Analysis of First-Line Zolbetuximab and Immunotherapy-Based Strategies in HER2-Negative Metastatic Gastric Cancer.

Oncology·2026

CCL5, CLEC11A, IL-7, IL-8, and IL-13: Diagnostic serum biomarkers of gastric cancer identified in a 48-multiplex panel.

Oncology·2026

Effects of amputation versus limb salvage surgery on the prognosis of primary extremity chondrosarcoma: Evidence from the Surveillance, Epidemiology, and End Results database.

Oncology·2026

Low Stromal CD11c Expression Indicates a Poor Prognosis in Rectal Cancer Patients.

Oncology·2026

Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil-Induced Neutropenia on Histological Tumor Response in Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Oncology·2026

Outcome-Guided Immunosuppressive Therapy and Clinical Events in Patients With Cardiac Sarcoidosis: An Observational Registry.

Journal of the American Heart Association·2026

Dual Functions of B7-H3-MAPK Signaling Orchestrate Tumor Immunosuppression via Regulating the Plasticity of Myeloid-derived Suppressor Cells and Fibroblasts.

Cancer discovery·2026

Rituximab as Salvage Therapy in Difficult-to-Treat Autoimmune Hepatitis: A Prospective Case Series.

Gastro hep advances·2026

Spatial Transcriptomics and Mechanisms of Immune Checkpoint Inhibitor-Associated Interstitial Nephritis.

Kidney international reports·2026

Exposure-response relationship of sintilimab in advanced gastric cancer: insights from time-dependent pharmacokinetics and biomarker integration for precision immunotherapy.

Frontiers in pharmacology·2026

FcRn Inhibition in Autoantibody-Mediated Autoimmune Diseases: From Broad Immunosuppression to Precision IgG Modulation.

Mediterranean journal of rheumatology·2026

Related Experiment Videos

L-asparaginase treatment of acute myeloblastic leukemia

Related Concept Videos

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.

Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.

Burnout: caring for the caregivers.

Glucose metabolism assessed by fluorodeoxyglucose positron emission tomography and response to chemoimmunotherapy in esophageal squamous cell carcinoma: An exploratory analysis.

Biomarker-Oriented Contextual Analysis of First-Line Zolbetuximab and Immunotherapy-Based Strategies in HER2-Negative Metastatic Gastric Cancer.

CCL5, CLEC11A, IL-7, IL-8, and IL-13: Diagnostic serum biomarkers of gastric cancer identified in a 48-multiplex panel.

Effects of amputation versus limb salvage surgery on the prognosis of primary extremity chondrosarcoma: Evidence from the Surveillance, Epidemiology, and End Results database.

Low Stromal CD11c Expression Indicates a Poor Prognosis in Rectal Cancer Patients.

Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil-Induced Neutropenia on Histological Tumor Response in Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Outcome-Guided Immunosuppressive Therapy and Clinical Events in Patients With Cardiac Sarcoidosis: An Observational Registry.

Dual Functions of B7-H3-MAPK Signaling Orchestrate Tumor Immunosuppression via Regulating the Plasticity of Myeloid-derived Suppressor Cells and Fibroblasts.

Rituximab as Salvage Therapy in Difficult-to-Treat Autoimmune Hepatitis: A Prospective Case Series.

Spatial Transcriptomics and Mechanisms of Immune Checkpoint Inhibitor-Associated Interstitial Nephritis.

Exposure-response relationship of sintilimab in advanced gastric cancer: insights from time-dependent pharmacokinetics and biomarker integration for precision immunotherapy.

FcRn Inhibition in Autoantibody-Mediated Autoimmune Diseases: From Broad Immunosuppression to Precision IgG Modulation.

Related Experiment Videos

L-asparaginase treatment of acute myeloblastic leukemia

Related Concept Videos

Related Articles